Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Wegovy FAQs How much does Wegovy cost
Limitations: - CT-388 data is early stage (Phase 1/2), making comparisons to late-stage or approved competitors regarding efficacy somewhat premature.- Competitor trials involving semaglutide and tirzepatide are based on larger patient populations and longer duration, providing a more robust data set validating their therapeutic benefit.- Weight loss achieved with GLP-1 receptor agonists such as semaglutide and the dual GLP-1/GIP receptor agonist tirzepatide appear greater than the weight loss observed to date with CT-388.- Competitor agents have established cardiovascular benefits and substantial net weight reductions, which set a high efficacy bar for CT-388 to meet or exceed.- Incretin therapies are challenged by supply shortages and complex titration schemes
"Persistent fatigue should not simply be dismissed as a normal side effect
Today, its market cap sits near $260B after shares fell nearly 60%, a steep decline for a company once viewed as untouchable
Frequently Asked Questions Is compounded semaglutide as safe as brand-name Ozempic
.jpg)
